< 1 2 3 4 >  Last ›

ACQUISITION OF PHARMACEUTICAL PROFILES EXPANDS EARLY-PHASE DRUG DEVELOPMENT SERVICE OFFERING

Date: 15/12/2008

Newmarket, United Kingdom, December 15, 2008 – Quotient Bioscience Group Limited ("Quotient"), a leading European provider of analytical and safety evaluation services and products for... Read More

---

Quotient Bioresearch completes a £4.5m investment of new purpose built laboratories at its Fordham site.

Date: 04/12/2008

CAMBRIDGE UK, 04 December 2008. Quotient Bioresearch, a leading provider of early phase drug development and sports testing services, is pleased to announce the completion of a £4.5M,... Read More

---

NHS spin-out Alba wins £1.8M from public purse

Date: 23/09/2008

Development funding -Alba Bioscience Ltd has been awarded a £1.8 million grant from the development agency Scottish Enterprise in the same week as the company’s owner Quotient... Read More

---

Alba Bioscience receives funding to secure 16 R&D jobs

Date: 17/09/2008

Edinburgh-based Alba Bioscience announced a major investment today (Tuesday 16 September 2008) to create and secure 16 high value research and development jobs and support the development of novel... Read More

---

Alba Bioscience secures investment of £10.7m to help expand product portfolio

Date: 17/09/2008

Alba Bioscience, the recently privatised former commercial arm of the Scottish National Blood Transfusion Service, has secured a £10.7m investment to help expand the company's product... Read More

---

Alba's £1.8m research cash secures jobs

Date: 16/09/2008

ALBA Bioscience, the Edinburgh-based biotechnology firm, yesterday secured £1.8 million in research and development funding from Scottish Enterprise. Read More

---